Budesonide Patents

Given below is the list of patents protecting Budesonide, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Budesonide's patents.

Latest Legal Activities on Budesonide's Patents

Given below is the list recent legal activities going on the following patents of Budesonide.

Activity	Date	Patent Number
Today's Critical Events
Maintenance Fee Reminder Mailed Critical	10 Jun, 2024	US8293273(Litigated)
Expire Patent Critical	03 Jun, 2024	US9320716
Email Notification Critical	27 Mar, 2024	US11896719
Patent eCofC Notification	26 Mar, 2024	US11896719
Mail Patent eCofC Notification	26 Mar, 2024	US11896719
Email Notification Critical	26 Mar, 2024	US11896719
Recordation of Patent eCertificate of Correction	26 Mar, 2024	US11896719
Post Issue Communication - Certificate of Correction	05 Mar, 2024	US11896719
Recordation of Patent eGrant	13 Feb, 2024	US11896719
Email Notification Critical	13 Feb, 2024	US11896719

Budesonide's Family Patents

Full family tree